pyrroles has been researched along with osteoprotegerin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaschke, S; Emons, G; Frosch, KH; Gründker, C; Hofbauer, LC; Schoppet, M; Viereck, V | 1 |
| Bandios, S; Fotiadis, G; Gerasimidis, T; Kadoglou, NP; Kapelouzou, A; Karayannacos, PE; Katinios, A; Kougias, P; Liapis, CD; Moumtzouoglou, A; Sailer, N; Vitta, I; Voliotis, K | 1 |
| Gerasimidis, T; Kadoglou, NP; Kapelouzou, A; Liapis, CD; Moumtzouoglou, A; Sailer, N | 1 |
| Avgerinos, ED; Gerasimidis, T; Kadoglou, NP; Kakisis, JD; Kapelouzou, A; Karayannacos, PE; Liapis, CD; Moumtzouoglou, A | 1 |
| Dimitrow, PP; Gackowski, A; Jawień, M | 1 |
| Dean, IN; Rawal, SY; Stein, SH; Tipton, DA | 1 |
| Gradosova, I; Palicka, V; Svejkovska, K; Tichy, A; Zivna, H; Zivny, P | 1 |
| Abuduwali, N; Deschner, J; Jäger, A; Kraus, D; Lossdörfer, S | 1 |
| Arnal, JF; Lucanus, E; Nickenig, G; Pelster, B; Steinmetz, M; Werner, N | 1 |
| Akiyama, Y; Araki, Y; Kayama, H; Kitaura, H; Mimura, T; Miyazaki, T; Miyoshi, F; Sato, K; Takeda, K; Yokota, K | 1 |
| Baretton, GB; Bauer, T; Benad-Mehner, P; Bornhäuser, M; Ebert, R; Göbel, A; Hadji, P; Hofbauer, LC; Jakob, F; Muders, MH; Rachner, TD; Rauner, M; Schem, C; Thiele, S | 1 |
| Bauer, I; Bertolotto, M; Dallegri, F; Fabre, M; Galan, K; Lenglet, S; Mach, F; Montecucco, F; Nencioni, A; Palombo, D; Pane, B; Pelli, G; Pende, A; Python, M; Quercioli, A; Spinella, G; Vuilleumier, N | 1 |
| Chang, I; Park, WS; Shin, DM; Son, GY; Yang, YM | 1 |
| Chen, G; He, Y; Jia, D; Liu, H; Lu, A; Zhu, Q; Zuo, C | 1 |
3 trial(s) available for pyrroles and osteoprotegerin
| Article | Year |
|---|---|
Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.
Topics: Aged; Atorvastatin; Biomarkers; Blood Pressure; C-Reactive Protein; Calcinosis; Carotid Stenosis; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Count; Male; Middle Aged; Osteopontin; Osteoprotegerin; Prospective Studies; Pyrroles; Severity of Illness Index; Treatment Outcome; Ultrasonography | 2008 |
Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
Topics: Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Carotid Stenosis; Cerebrovascular Disorders; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Osteopontin; Osteoprotegerin; Prospective Studies; Pyrroles; Severity of Illness Index; Time Factors; Treatment Outcome; Ultrasonography, Doppler | 2010 |
The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis.
Topics: Aged; Aortic Valve Stenosis; Atorvastatin; Biomarkers; Calcinosis; Down-Regulation; Drug Administration Schedule; Echocardiography, Doppler; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteopontin; Osteoprotegerin; Poland; Pyrroles; RANK Ligand; Sclerosis; Severity of Illness Index; Time Factors; Treatment Outcome | 2011 |
11 other study(ies) available for pyrroles and osteoprotegerin
| Article | Year |
|---|---|
Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
Topics: Adult; Atorvastatin; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Female; Glucocorticoids; Glycoproteins; Heptanoic Acids; Humans; Male; Mevalonic Acid; Models, Biological; Osteoblasts; Osteoprotegerin; Pyrroles; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |
Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.
Topics: Aged; Angioplasty; Atorvastatin; Biomarkers; C-Reactive Protein; Calcinosis; Carotid Stenosis; Combined Modality Therapy; Down-Regulation; Female; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteopontin; Osteoprotegerin; Prospective Studies; Pyrroles; Severity of Illness Index; Stents; Time Factors; Treatment Outcome; Ultrasonography, Doppler | 2010 |
Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts.
Topics: Atorvastatin; Cell Culture Techniques; Cell Survival; Cells, Cultured; Coloring Agents; Culture Media, Serum-Free; Fibroblasts; Gingiva; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Osteoprotegerin; Pyrroles; RANK Ligand; Simvastatin; Temperature; Tetrazolium Salts; Thiazoles; Time Factors | 2011 |
The role of atorvastatin in bone metabolism in male albino Wistar rats.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Atorvastatin; Biomarkers; Biomechanical Phenomena; Blotting, Western; Bone and Bones; Bone Density; Bone Morphogenetic Protein 2; Collagen Type I; Electrophoresis, Polyacrylamide Gel; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteocalcin; Osteoprotegerin; Peptide Fragments; Procollagen; Protein Prenylation; Pyrroles; Rats; Rats, Wistar | 2011 |
Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.
Topics: Adolescent; Cell Culture Techniques; Child; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Isoquinolines; Osteoprotegerin; Parathyroid Hormone; Peptide Fragments; Periodontal Ligament; Protein Kinase C; Pyrroles; Signal Transduction; Teriparatide | 2012 |
Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization.
Topics: Animals; Antigens, Ly; Atorvastatin; Bone Marrow; Cell Proliferation; Fibroblast Growth Factor 2; Heptanoic Acids; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Physiologic; Osteoprotegerin; Perfusion; Pyrroles; RANK Ligand; Re-Epithelialization; Stem Cells; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo.
Topics: Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Interleukin-6; Macrophages; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteoprotegerin; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fos; Pyrimidines; Pyrroles; RANK Ligand; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha | 2014 |
Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Bone Density Conservation Agents; Bone Neoplasms; cdc42 GTP-Binding Protein; Cell Line, Tumor; Diphosphonates; Female; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; L Cells; Lymphocyte Activation; MCF-7 Cells; Mevalonic Acid; Mice; Osteoblasts; Osteogenesis; Osteoprotegerin; Prenylation; Pyrroles; Rho Factor; RNA Interference; RNA, Small Interfering; Triple Negative Breast Neoplasms; Wnt3A Protein; Zoledronic Acid | 2014 |
Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.
Topics: Aged; Atherosclerosis; Atorvastatin; Carotid Stenosis; Cohort Studies; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Matrix Metalloproteinase 9; Middle Aged; Neutrophil Activation; Neutrophils; NF-kappa B; Osteopontin; Osteoprotegerin; Pyrimidines; Pyrroles; RANK Ligand; Risk Factors; RNA, Messenger; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2014 |
Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells.
Topics: Biomechanical Phenomena; Bone Remodeling; Boron Compounds; Calcium Channel Blockers; Calcium Signaling; Cell Culture Techniques; Cells, Cultured; Gene Silencing; Humans; Hypotonic Solutions; Morpholines; Osteoprotegerin; Periodontal Ligament; Phorbols; Pregnenolone; Pyrroles; RANK Ligand; RNA, Messenger; RNA, Small Interfering; Ruthenium Red; Signal Transduction; Stress, Mechanical; TRPM Cation Channels; TRPV Cation Channels | 2015 |
Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
Topics: Animals; Arterial Pressure; Case-Control Studies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Female; Focal Adhesion Kinase 1; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Integrin alphaVbeta3; Male; Mice, Knockout; Middle Aged; Monocrotaline; Muscle, Smooth, Vascular; Osteoprotegerin; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Pyrroles; Rats, Sprague-Dawley; RNA Interference; Severity of Illness Index; Signal Transduction; Transfection; Vascular Remodeling; Walk Test | 2017 |